CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Bristol-Myers Squibb Co. said on Friday that U.S. regulators approved a single-capsule form of its Reyataz HIV drug to be taken as part of combination drug therapy. Taken once a day, the 300-milligram Reyataz can replace two 150-milligram capsules of the drug and will be available within a week, the company said. (Reuters)
From our Sponsors
Most Popular
Watch Now: Advocate Channel
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Trending Stories & News
For more news and videos on advocatechannel.com, click here.
Latest Stories
Advocate Channel
HealthAdvocate Channel
WomenMuslim Women Athletes Condemn Hijab Bans, Fight For Inclusive Clothing in Sports
January 17 2023 11:45 AM
Advocate Channel
Police